PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.34 - 0.34
0.23 - 0.41
110.0K / 51.2K (Avg.)
-1.33 | -0.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
139.63%
Revenue growth of 139.63% while 0455.HK is flat. Bruce Berkowitz would check if a small edge can widen further.
-6.61%
Negative gross profit growth while 0455.HK is at 0.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
No Data
No Data available this quarter, please select a different quarter.
27.23%
Operating income growth of 27.23% while 0455.HK is zero. Bruce Berkowitz would see if this modest edge can become significant.
33.87%
Net income growth of 33.87% while 0455.HK is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
31.25%
EPS growth of 31.25% while 0455.HK is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
31.25%
Diluted EPS growth of 31.25% while 0455.HK is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
0.00%
Share change of 0.00% while 0455.HK is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-121.39%
Negative OCF growth while 0455.HK is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-116.54%
Negative FCF growth while 0455.HK is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-87.78%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-88.16%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-60.23%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
13.79%
Positive long-term OCF/share growth while 0455.HK is negative. John Neff would see a structural advantage in sustained cash generation.
38.22%
Positive OCF/share growth while 0455.HK is negative. John Neff might see a comparative advantage in operational cash viability.
-49.02%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-264.27%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-5490.50%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-473.19%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-7.01%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-24.07%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-19.64%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-100.00%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-100.00%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-100.00%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
84.92%
AR growth of 84.92% while 0455.HK is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
-0.29%
Inventory is declining while 0455.HK stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-10.95%
Negative asset growth while 0455.HK invests at 0.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-6.95%
We have a declining book value while 0455.HK shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-36.45%
We’re deleveraging while 0455.HK stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Our R&D shrinks while 0455.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-22.46%
We cut SG&A while 0455.HK invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.